
Sham FoamNSE SME / BSE SME:
Is Sham Foam IPO Good? Quick Verdict
Sham Foam IPO scored 73/100 (Moderate Risk) in our deep analysis. The strongest pillar is Dilution at 80/100, while Competition is the primary concern at 55/100. Sham Foam Limited is a growing PU foam and mattress manufacturer with solid profitability and low debt, but faces single-facility and customer concentration risks.
Quick Verdict
Company Snapshot
Risk Breakdown
AI Summary
Sham Foam Limited is an Indian manufacturer of polyurethane (PU) foam, mattresses, pillows, furniture cushions, and customized industrial-grade PU foam products sold under brands such as Featherfresh and Restivia. Operating a 2,04,460 sq. ft. manufacturing facility in Ambala, Haryana with an installed capacity of 15,000 TPA, the company distributes across 13 Indian states through a network of over 1,300 dealers. Through its ₹40.48 Crore SME IPO on BSE SME, Sham Foam Limited aims to fund facility expansion, purchase machinery, and support working capital requirements. The company has demonstrated strong financial momentum, increasing its annual revenue to ₹92.31 Crore and profit after tax to ₹8.65 Crore in FY26.
Key Highlights
- •Operates an in-house manufacturing facility in Ambala, Haryana (2,04,460 sq. ft.) with an installed PU foam capacity of 15,000 TPA.
- •Markets home comfort products under proprietary brands Featherfresh and Restivia alongside industrial-grade PU foam.
- •Maintains an extensive network of over 1,300 dealers across 13 states and Union Territories in India.
- •ISO 9001:2015 quality management certified and holds BIS Certification No. IS 7933:2022.
- •Financial growth trajectory showed revenue expanding from ₹73.72 Crore in FY24 to ₹92.31 Crore in FY26.
- •Net profit margin expanded significantly to 9.37% with PAT reaching ₹8.65 Crore in FY26.
Financial Performance
Revenue (Annual) Total money brought in by the company's operations before deducting any expenses.
↑ +13.8% YoYINR in Crores
Net Income (Annual) The company's total profit after all expenses, taxes, and costs have been deducted.
↑ +141.6% YoYINR in Crores
EBITDA vs PAT Earnings Before Interest, Taxes, Depreciation, and Amortization. Shows pure operating performance.
↑ +106.8% YoYINR in Crores
IPO Timeline
Valuation Analysis
IPO DNA
Pros vs Cons
Pros
- High return capital efficiency with ROE of 81.95% and ROCE of 45.73%.
- Low financial leverage with a healthy Debt-to-Equity ratio of 0.19.
- In-house production capability with 15,000 TPA installed capacity supporting product customization.
- Wide pan-India distribution network with 1,300+ dealers in 13 states/UTs.
Cons
- Revenue reliance on a limited number of major clients.
- Single manufacturing facility exposure in Ambala, Haryana.
- Lack of long-term formal agreements with key suppliers and dealers.
- Past history of negative operating cash flows and high working capital intensity.
Financial Health
Institutional Signals
Sham Foam IPO — Frequently Asked Questions
Related IPO Reports

Shiprocket
SHIP
Behari Lal Engineering
BLEL
Milky Mist Dairy Food
MILKYMIST
Fascinate Textiles
FASCINATE
Molbio Diagnostics
MOLBIOSource Citation: All financial data and risk metrics are derived from the official prospectus filed with the regulator (SEBI DRHP/RHP). ViewIPO algorithms process this public data for informational purposes. Not financial advice.
Want to analyze another IPO?
Search any IPO, company, ticker or filing and get instant AI-powered analysis.
